180 mg
Trade Name
Bimpdix
Film-coated tablet
Request Type
New Registration
Drug Type
Generic(Multisource) Drug
Approval Date
SFDA Approved Use
Hypercholesterolaemia and mixed dyslipidaemia
Bempedoic Acid is indicated in adults with primary hypercholesterolaemia (heterozygous familial and nonfamilial) or mixed dyslipidaemia, as an adjunct to diet:
·in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach LDL-C goals with the maximum tolerated dose of a statin or,
·alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.
Cardiovascular disease
Bempedoic Acid is indicated in adults with established or at high risk for atherosclerotic cardiovascular disease to reduce cardiovascular risk by lowering LDL-C levels, as an adjunct to correction of other risk factors:
·in patients on a maximum tolerated dose of a statin with or without ezetimibe or,
·alone or in combination with ezetimibe in patients who are statin-intolerant, or for whom a statin is contraindicated
Bempedoic Acid is indicated in adults with primary hypercholesterolaemia (heterozygous familial and nonfamilial) or mixed dyslipidaemia, as an adjunct to diet:
·in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach LDL-C goals with the maximum tolerated dose of a statin or,
·alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.
Cardiovascular disease
Bempedoic Acid is indicated in adults with established or at high risk for atherosclerotic cardiovascular disease to reduce cardiovascular risk by lowering LDL-C levels, as an adjunct to correction of other risk factors:
·in patients on a maximum tolerated dose of a statin with or without ezetimibe or,
·alone or in combination with ezetimibe in patients who are statin-intolerant, or for whom a statin is contraindicated